Stephan B. Dreyer

2.1k total citations
19 papers, 356 citations indexed

About

Stephan B. Dreyer is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Stephan B. Dreyer has authored 19 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Cancer Research and 6 papers in Surgery. Recurrent topics in Stephan B. Dreyer's work include Pancreatic and Hepatic Oncology Research (14 papers), Cancer Genomics and Diagnostics (14 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Stephan B. Dreyer is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Cancer Genomics and Diagnostics (14 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Stephan B. Dreyer collaborates with scholars based in United Kingdom, Australia and Italy. Stephan B. Dreyer's co-authors include David K. Chang, Andrew V. Biankin, Peter J. Bailey, Rosanna Upstill‐Goddard, Nigel B. Jamieson, C. McKay, Fieke E. M. Froeling, Donald C. McMillan, Joanne Edwards and Arfon Powell and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.

In The Last Decade

Stephan B. Dreyer

19 papers receiving 351 citations

Peers

Stephan B. Dreyer
Stephan B. Dreyer
Citations per year, relative to Stephan B. Dreyer Stephan B. Dreyer (= 1×) peers Paola Mattiolo

Countries citing papers authored by Stephan B. Dreyer

Since Specialization
Citations

This map shows the geographic impact of Stephan B. Dreyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan B. Dreyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan B. Dreyer more than expected).

Fields of papers citing papers by Stephan B. Dreyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan B. Dreyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan B. Dreyer. The network helps show where Stephan B. Dreyer may publish in the future.

Co-authorship network of co-authors of Stephan B. Dreyer

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan B. Dreyer. A scholar is included among the top collaborators of Stephan B. Dreyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan B. Dreyer. Stephan B. Dreyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Dreyer, Stephan B., Philip Beer, Sunil R. Hingorani, & Andrew V. Biankin. (2025). Improving outcomes of patients with pancreatic cancer. Nature Reviews Clinical Oncology. 22(6). 439–456. 5 indexed citations
2.
Herbert, Katharine, Rosanna Upstill‐Goddard, Stephan B. Dreyer, et al.. (2025). Sequential ATR and PARP inhibition overcomes acquired DNA damaging agent resistance in pancreatic ductal adenocarcinoma. British Journal of Cancer. 133(3). 381–393. 1 indexed citations
3.
Jamieson, Nigel B., et al.. (2022). High-plex proteomic prognostic marker discovery for patients with pancreatic cancer adenocarcinoma using digital spatial profiling.. Journal of Clinical Oncology. 40(4_suppl). 611–611. 1 indexed citations
4.
Dreyer, Stephan B., et al.. (2022). Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence. HPB. 24. S44–S45. 2 indexed citations
5.
Gall, Lewis, et al.. (2022). Stage migration in newly diagnosed oesophagogastric cancer during the first wave of the COVID-19 pandemic. British journal of surgery. 109(8). 773–774. 3 indexed citations
6.
Dreyer, Stephan B., et al.. (2022). Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer. Cancers. 14(21). 5302–5302. 12 indexed citations
7.
Dreyer, Stephan B., S. Rae, Rosanna Upstill‐Goddard, et al.. (2021). The Impact of Molecular Subtyping on Pathological Staging of Pancreatic Cancer. HPB. 23. S749–S749. 1 indexed citations
8.
Casolino, Raffaella, Chiara Braconi, Giuseppe Malleo, et al.. (2020). Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. Annals of Oncology. 32(2). 183–196. 43 indexed citations
9.
Dreyer, Stephan B., Nigel B. Jamieson, Lisa Evers, et al.. (2019). Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling. Chinese Clinical Oncology. 8(2). 16–16. 23 indexed citations
10.
Dreyer, Stephan B., Viola Paulus-Hock, Rosanna Upstill‐Goddard, et al.. (2019). Defining DNA damage repair deficiency and replication stress in pancreatic cancer.. Journal of Clinical Oncology. 37(4_suppl). 285–285. 2 indexed citations
11.
Dreyer, Stephan B., Nigel B. Jamieson, Lisa Evers, et al.. (2018). Feasibility and clinical utility of EUS guided biopsy of pancreatic cancer for next-generation genomic sequencing.. Journal of Clinical Oncology. 36(4_suppl). 296–296. 1 indexed citations
12.
Dreyer, Stephan B., Nigel B. Jamieson, Rosanna Upstill‐Goddard, et al.. (2018). Defining the molecular pathology of pancreatic body and tail adenocarcinoma. British journal of surgery. 105(2). e183–e191. 75 indexed citations
13.
Dreyer, Stephan B., Mark Pinese, Nigel B. Jamieson, et al.. (2018). 10. Precision Oncology in Surgery: Patient Selection Biomarkers for Operable Pancreatic Cancer. European Journal of Surgical Oncology. 44(11). 1838–1838. 4 indexed citations
14.
Dreyer, Stephan B., David K. Chang, Peter J. Bailey, & Andrew V. Biankin. (2017). Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development. Clinical Cancer Research. 23(7). 1638–1646. 128 indexed citations
15.
Dreyer, Stephan B., et al.. (2017). Defining DDR defectiveness in pancreatic cancer.. Journal of Clinical Oncology. 35(15_suppl). 4115–4115. 1 indexed citations
16.
Dreyer, Stephan B., Arfon Powell, Stephen T. McSorley, et al.. (2016). The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer. Annals of Surgical Oncology. 24(5). 1295–1303. 38 indexed citations
17.
Dreyer, Stephan B., et al.. (2014). Reverse intestinal rotation: a rare case of volvulus around a vitelline duct remnant. BMJ Case Reports. 2014. bcr2014204107–bcr2014204107. 2 indexed citations
18.
Dreyer, Stephan B. & Paul Burns. (2014). Ruptured abdominal aortic aneurysms: decreasing incidence may reduce the impact of a Scottish screening programme. Scottish Medical Journal. 60(1). 23–28. 2 indexed citations
19.
Kieser, David, David Gwynne‐Jones, & Stephan B. Dreyer. (2011). Displaced Tibial Intercondylar Eminence Fractures. Journal of orthopaedic surgery. 19(3). 292–296. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026